| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Department of Anatomy and Embryology, Biomolecular and Integrated Medical Sciences, 2 Pathophysiology of Renal Diseases, Medical Sciences for Control of Pathological Processes, 3 Clinical and Experimental Hematology, Major of Advanced Biomedical Applications, 4 Graduate School of Comprehensive Human Sciences, Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba, Japan; 5 Department of Internal Medicine II, Kumamoto University School of Medicine, Kumamoto, Japan; 6 Cancer Physiology Project, National Cancer Center Research Institute East, Chiba, Japan; and 7 Department of Pathology of Biological Response, Nagoya University Graduate School of Medicine, Nagoya, Japan
Requests for reprints: Satoru Takahashi, Department of Anatomy and Embryology, Biomolecular and Integrated Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Japan. Phone: 81-298-53-7516; Fax: 81-298-53-6965; E-mail: satoruta{at}md.tsukuba.ac.jp.
c-Maf translocation or overexpression has been observed in human multiple myeloma. Although c-maf might function as an oncogene in multiple myeloma, a role for this gene in other cancers has not been shown. In this study, we have found that mice transgenic for c-Maf whose expression was direct to the T-cell compartment developed T-cell lymphoma. Moreover, we showed that cyclin D2, integrin ß7, and ARK5 were up-regulated in c-Maf transgenic lymphoma cells. Furthermore, 60% of human T-cell lymphomas (11 of 18 cases), classified as angioimmunoblastic T-cell lymphoma, were found to express c-Maf. These results suggest that c-Maf might cause a type of T-cell lymphoma in both mice and humans and that ARK5, in addition to cyclin D2 and integrin ß7, might be downstream target genes of c-Maf leading to malignant transformation. (Cancer Res 2006; 66(2): 812-9)
This article has been cited by other articles:
![]() |
Y. Natkunam, S. Tedoldi, J. C. Paterson, S. Zhao, M. Rodriguez-Justo, A. H. Beck, R. Siebert, D. Y. Mason, and T. Marafioti Characterization of c-Maf Transcription Factor in Normal and Neoplastic Hematolymphoid Tissue and Its Relevance in Plasma Cell Neoplasia Am J Clin Pathol, September 1, 2009; 132(3): 361 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-T. Tai, E. Soydan, W. Song, M. Fulciniti, K. Kim, F. Hong, X.-F. Li, P. Burger, M. J. Rumizen, S. Nahar, et al. CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells Blood, April 30, 2009; 113(18): 4309 - 4318. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Z. Torabian, D. de Semir, M. Nosrati, S. Bagheri, A. A. Dar, S. Fong, Y. Liu, S. Federman, J. Simko, C. Haqq, et al. Ribozyme-Mediated Targeting of I{kappa}B{gamma} Inhibits Melanoma Invasion and Metastasis Am. J. Pathol., March 1, 2009; 174(3): 1009 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Mao, A. K. Stewart, R. Hurren, A. Datti, X. Zhu, Y. Zhu, C. Shi, K. Lee, R. Tiedemann, Y. Eberhard, et al. A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin Blood, December 1, 2007; 110(12): 4047 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Moreaux, D. Hose, M. Jourdan, T. Reme, M. Hundemer, M. Moos, N. Robert, P. Moine, J. De Vos, H. Goldschmidt, et al. TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines Haematologica, June 1, 2007; 92(6): 803 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Mukai, H. Motohashi, O. Ohneda, N. Suzuki, M. Nagano, and M. Yamamoto Transgene Insertion in Proximity to thec-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation Mol. Cell. Biol., November 1, 2006; 26(21): 7953 - 7965. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |